摘要
目前大多数给药方式通常为长期循环,这样有利于在靶组织积累。对李子进行有效的表面改性设计,可确定了其较长的循环时间和靶向能力。优化合成方案,有效地结合靶向分子和元素,增加循环时间具有很大挑战性,同时需要几个功能元素几乎是不可能的。另一方面,在过去的十年中,仿生技术的发展在增加粒子的安全性,生物相容性和靶向性,同时保持合成方案简单和可重复性等方面提出了新方法。最近,我们开发了一种新的药物输送系统,被称为leukolike向量(LLV)的免疫细胞生物,由纳米多孔硅芯和白细胞的细胞膜形成的壳组成。本研究的目的是探讨LLV蛋白质含量。本文报道了LLV的蛋白质组学分析, 并证明本研究方法使用超过150白细胞膜蛋白用于修改合成颗粒表面特性,以确定粒子对发炎的内皮细胞的安全性,循环时间和靶向能力。
关键词: 仿生掩饰,药物输送,白细胞,白细胞样载体,膜,纳米技术,纳米微粒,蛋白质组学。
图形摘要
Current Drug Targets
Title:Proteomic Profiling of a Biomimetic Drug Delivery Platform
Volume: 16 Issue: 13
Author(s): Claudia Corbo, Alessandro Parodi, Michael Evangelopoulos, David A. Engler, Rise K. Matsunami, Anthony C. Engler and Roberto Molinaro, Shilpa Scaria, Francesco Salvatore and Ennio Tasciotti
Affiliation:
关键词: 仿生掩饰,药物输送,白细胞,白细胞样载体,膜,纳米技术,纳米微粒,蛋白质组学。
摘要: Current delivery platforms are typically designed for prolonged circulation that favors superior accumulation of the payload in the targeted tissue. The design of efficient surface modifications determines both a longer circulation time and targeting abilities of particles. The optimization of synthesis protocols to efficiently combine targeting molecules and elements that allow for an increased circulation time can be challenging and almost impossible when several functional elements are needed. On the other hand, in the last decade, the development of bioinspired technologies was proposed as a new approach with which to increase particle safety, biocompatibility and targeting, while maintaining the synthesis protocols simple and reproducible. Recently, we developed a new drug delivery system inspired by the biology of immune cells called leukolike vector (LLV) and formed by a nanoporous silicon core and a shell derived from the leucocyte cell membrane. The goal of this study is to investigate the protein content of the LLV. Here we report the proteomic profiling of the LLV and demonstrate that our approach can be used to modify the surface of synthetic particles with more than 150 leukocyte membraneassociated proteins that determine particle safety, circulation time and targeting abilities towards inflamed endothelium.
Export Options
About this article
Cite this article as:
Claudia Corbo, Alessandro Parodi, Michael Evangelopoulos, David A. Engler, Rise K. Matsunami, Anthony C. Engler and Roberto Molinaro, Shilpa Scaria, Francesco Salvatore and Ennio Tasciotti , Proteomic Profiling of a Biomimetic Drug Delivery Platform, Current Drug Targets 2015; 16 (13) . https://dx.doi.org/10.2174/1389450115666141109211413
DOI https://dx.doi.org/10.2174/1389450115666141109211413 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Bee Venom: Its Potential Use in Alternative Medicine
Anti-Infective Agents New Hybrids with 2-aminobenzothiazole and Azelayl Scaffolds: Synthesis, Molecular Docking and Biological Evaluation
Current Organic Chemistry Structure-based Virtual Screening for the Identification of High-affinity Small Molecule Towards STAT3 for the Clinical Treatment of Osteosarcoma
Current Topics in Medicinal Chemistry PET Imaging to Monitor Cancer Therapy
Current Pharmaceutical Biotechnology Biological Applications of ZnO Nanoparticles
Current Molecular Imaging (Discontinued) Quinones Derived from Plant Secondary Metabolites as Anti-cancer Agents
Anti-Cancer Agents in Medicinal Chemistry Synthesis of Oridonin Derivatives via Mizoroki-Heck Reaction and Click Chemistry for Cytotoxic Activity
Anti-Cancer Agents in Medicinal Chemistry Pathobiology and Therapeutic Implications of Tumor Acidosis
Current Medicinal Chemistry The Role of Anionic Polysaccharides in the Preparation of Nanomedicines with Anticancer Applications
Current Pharmaceutical Design Co-opting Functions of Cholinesterases in Neural, Limb and Stem Cell Development
Protein & Peptide Letters Antiproliferative and Antifungal Activities of 1,3-diarylpropane-1,3-diones Commonly used as Sunscreen Agents
Letters in Drug Design & Discovery Development on PEG-modified Poly (Amino Acid) Copolymeric Micelles for Delivery of Anticancer Drug
Anti-Cancer Agents in Medicinal Chemistry Targeting ABCB1 and ABCC1 with their Specific Inhibitor CBT-1<sup>®</sup> can Overcome Drug Resistance in Osteosarcoma
Current Cancer Drug Targets Perspectives in Breast and Ovarian Cancer Chemotherapy by Nanomedicine Approach: Nanoformulations in Clinical Research
Current Medicinal Chemistry From Bortezomib to other Inhibitors of the Proteasome and Beyond
Current Pharmaceutical Design Drugs of Abuse: Epigenetic Mechanisms in Toxicity and Addiction
Current Medicinal Chemistry DLEU2: A Meaningful Long Noncoding RNA in Oncogenesis
Current Pharmaceutical Design The Role of Cellular Plasticity in Cancer Development
Current Medicinal Chemistry Nanosponges Encapsulated Phytochemicals for Targeting Cancer: A Review
Current Drug Targets Probing Gallic Acid for Its Broad Spectrum Applications
Mini-Reviews in Medicinal Chemistry